TY - JOUR
T1 - p21 and p27
T2 - Roles in carcinogenesis and drug resistance
AU - Abukhdeir, Abde M.
AU - Park, Ben Ho
PY - 2008/7
Y1 - 2008/7
N2 - Human cancers arise from an imbalance of cell growth and cell death. Key proteins that govern this balance are those that mediate the cell cycle. Several different molecular effectors have been identified that tightly regulate specific phases of the cell cycle, including cyclins, cyclin-dependent kinases (CDKs) and CDK inhibitors. Notably, loss of expression or function of two G1-checkpoint CDK inhibitors - p21 (CDKN1A) and p27 (CDKN1B) - has been implicated in the genesis or progression of many human malignancies. Additionally, there is a growing body of evidence suggesting that functional loss of p21 or p27 can mediate a drug-resistance phenotype. However, reports in the literature have also suggested p21 and p27 can promote tumours, indicating a paradoxical effect. Here, we review historic and recent studies of these two CDK inhibitors, including their identification, function, importance to carcinogenesis and finally their roles in drug resistance.
AB - Human cancers arise from an imbalance of cell growth and cell death. Key proteins that govern this balance are those that mediate the cell cycle. Several different molecular effectors have been identified that tightly regulate specific phases of the cell cycle, including cyclins, cyclin-dependent kinases (CDKs) and CDK inhibitors. Notably, loss of expression or function of two G1-checkpoint CDK inhibitors - p21 (CDKN1A) and p27 (CDKN1B) - has been implicated in the genesis or progression of many human malignancies. Additionally, there is a growing body of evidence suggesting that functional loss of p21 or p27 can mediate a drug-resistance phenotype. However, reports in the literature have also suggested p21 and p27 can promote tumours, indicating a paradoxical effect. Here, we review historic and recent studies of these two CDK inhibitors, including their identification, function, importance to carcinogenesis and finally their roles in drug resistance.
UR - http://www.scopus.com/inward/record.url?scp=47149085982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=47149085982&partnerID=8YFLogxK
U2 - 10.1017/S1462399408000744
DO - 10.1017/S1462399408000744
M3 - Review article
C2 - 18590585
AN - SCOPUS:47149085982
VL - 10
JO - Expert Reviews in Molecular Medicine
JF - Expert Reviews in Molecular Medicine
SN - 1462-3994
IS - 19
ER -